Hims & Hers Health vs Teladoc Health
HIMS and TDOC side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HIMS and TDOC compare
Hims & Hers Health is the larger company, worth 2.9 times as much as Teladoc Health ($4.6B against $1.6B).
Hims & Hers Health grew revenue faster over the last twelve months (29.8% versus −2.4% for Teladoc Health).
Teladoc Health keeps more of each dollar of sales as profit, with a net margin of −6.3% compared with −6.7% at Hims & Hers Health.
Hims & Hers Health scores higher on the StockData Score (8 against 4 for Teladoc Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HIMS | TDOC |
|---|---|---|
| Size and price | ||
| Market cap | $4.6B | $1.6B |
| Share price | $19.73 | $8.80 |
| Change, 1 year | −49.4% | 17.8% |
| Change, 5 years | 170% | −92.5% |
| Beta (5Y) | 2.03 | 1.97 |
| Employees | 1,046 | 5,600 |
| StockData Score | ||
| Total score | 8 (better) | 4 |
| Valuation score | 0 | 3 (better) |
| Growth score | 3 (better) | 0 |
| Performance score | 1 | 1 |
| Health score | 4 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.6× | 0.6× (better) |
| P/B | 13.0× | 1.2× (better) |
| P/FCF | 560× | 6.1× (better) |
| FCF yield | 0.18% | 16.3% (better) |
| Fair value | $6.77 | $13.40 |
| Margin of safety | −191% | 34.4% (better) |
| Growth | ||
| Revenue growth (TTM) | 29.8% (better) | −2.4% |
| Revenue growth, 5Y average | 73.6% (better) | 18.3% |
| Net income growth (TTM) | −243% | – |
| EPS growth (TTM) | −254% | – |
| Profitability | ||
| Gross margin | 63.8% | 68.6% (better) |
| Operating margin | −8.1% | −6.6% (better) |
| Net margin | −6.7% | −6.3% (better) |
| FCF margin | 0.29% | 10.6% (better) |
| Return on equity | −40.8% | −11.5% (better) |
| Return on invested capital | – | −23.2% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −8.0× |
| Current ratio | 0.92 (better) | 0.87 |
| Altman Z-score | 1.29 (better) | −7.09 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 67.1% | 83.6% |
| Held by insiders | 10.9% | 0.71% |
| Insider net buying, 12 months | −$17.1M | −$2.7M (better) |
| Short interest, % of float | 24.9% | 17.8% |
Go deeper
- HIMS stock overview
- HIMS income statement
- HIMS valuation and score
- TDOC stock overview
- TDOC income statement
- TDOC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.